Jazz Pharma's sleep disorder drug gets European panel backing
Jazz Pharmaceuticals Plc's treatment for a form of sleep disorder has been recommended for approval in Europe by a panel of the European Medicines Agency (EMA), the regulator said on Friday.
No comments:
Post a Comment